Zobrazeno 1 - 10
of 44
pro vyhledávání: '"L C, Hartmann"'
Autor:
Derek C. Radisky, Amy C. Degnim, N Aziza, Ryan D. Frank, Celine M. Vachon, Marlene H. Frost, RA Vierkant, DW Visscher, Vernon S. Pankratz, L. C. Hartmann, Karthik Ghosh
Publikováno v:
Cancer Research. 72:P4-12
Background: Optimal early detection and prevention strategies for breast cancer are predicated on our ability to accurately identify women at increased risk for disease. Current breast cancer risk prediction models rely on clinical and epidemiologic
Autor:
Julie J. Ruterbusch, L. C. Hartmann, B. Alosh, Sudeshna Bandyopadhyay, B Albashiti, DW Visscher, Marlene H. Frost, RA Fehmi, Michele L. Cote
Publikováno v:
Cancer Research. 71:P1-08
African American (AA) women have higher mortality rates from breast cancer (BrCa) and are diagnosed at younger ages than their Caucasian counterparts. Women who have had a benign breast biopsy are at increased risk of the disease, although less is kn
Autor:
B Albashiti, L. C. Hartmann, DW Visscher, Julie J. Ruterbusch, B. Alosh, Sudeshna Bandyopadhyay, Marlene H. Frost, Michele L. Cote, RA Fehmi
Publikováno v:
Cancer Research. 71:P2-11
Invasive breast carcinoma in African American (AA) women differs significantly from their Caucasian (CA) counterparts in its incidence, morphology and outcome. These tumors are more likely to be high grade, hormone receptor negative, present at a you
Autor:
L. C. Hartmann, Tina J. Hieken, Daniel W. Visscher, Robert A. Vierkant, Ryan D. Frank, Derek C. Radisky, Karthik Ghosh, V. Shane Pankratz, Amy C. Degnim, Yaman Tarabishy, Celine M. Vachon, Marlene H. Frost
Purpose Optimal early detection and prevention for breast cancer depend on accurate identification of women at increased risk. We present a risk prediction model that incorporates histologic features of biopsy tissues from women with benign breast di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0177122b09162f87c6df2ba37e0847a7
https://europepmc.org/articles/PMC4348637/
https://europepmc.org/articles/PMC4348637/
Publikováno v:
Cancer Detection and Prevention. 28:357-360
Purpose : We investigated whether removal of the ovaries is an appropriate risk reduction option for women at elevated risk of breast cancer based on family history of breast cancer. Patients and methods : This question was investigated among a group
Autor:
James N. Ingle, L. C. Hartmann, Clive S. Grant, Michele Y. Halyard, Lester E. Wold, Gordon L. Grado, Thomas M. Pisansky, John H. Donohue, Paula J. Schomberg, Amy L. Weaver
Publikováno v:
Mayo Clinic Proceedings. 69:515-524
Objective To assess the role of breast conservation therapy in the management of early-stage invasive breast cancer. Design We reviewed the results of previously published trials and summarized 165 cases of breast conservation surgical procedures and
Autor:
Ann L. Oberg, S. John Weroha, Prema P. Peethambaram, Katie L. Allen Ziegler, Paul Haluska, Kendrith M. Rowland, Gary L. Keeney, Shaker R. Dakhilm, L. C. Hartmann, Dennis F. Moore
Publikováno v:
Gynecologic oncology. 122(1)
Objective Resistance to chemotherapy is a major challenge in the treatment of ovarian/peritoneal cancer. One purported mechanism of topotecan resistance is the breast cancer resistance protein (BCRP) and P-glycoprotein (Pgp). We designed a phase II c
Autor:
J. A. Jefferies, L. C. Hartmann, W. J. Maples, Tom R. Fitch, Gerardo Colon-Otero, Harry J. Long, T. A. Braich, John H. Edmonson
Publikováno v:
Cancer. 70:2529-2539
Background. In an attempt to learn how best to administer granulocyte-macrophage colony-stimulating factor (GMCSF), the authors performed a Phase I study of this agent. They were interested in the influences of dose, schedule, and route of administra
Autor:
Carol Reynolds, Hal K. Berman, Lois Penheiter, Amy C. Degnim, Shaun D. Maloney, Thomas A. Sellers, Piet C. de Groen, L. Joseph Melton, Marlene H. Frost, Robert A. Vierkant, L. C. Hartmann, V. Shane Pankratz, Daniel W. Visscher, Wilma L. Lingle, Karthik Ghosh, Thea D. Tlsty
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 25, iss 19
Purpose Atypical hyperplasia is a well-recognized risk factor for breast cancer, conveying an approximately four-fold increased risk. Data regarding long-term absolute risk and factors for risk stratification are needed. Patients and Methods Women wi
Autor:
L A, Boardman, F J, Couch, L J, Burgart, D, Schwartz, R, Berry, S K, McDonnell, D J, Schaid, L C, Hartmann, J J, Schroeder, C A, Stratakis, S N, Thibodeau
Publikováno v:
Human mutation. 16(1)
LKB1, the human gene encoding a serine threonine kinase, was recently identified as a susceptibility gene for Peutz-Jeghers syndrome (PJS), a disease characterized by the constellation of intestinal hamartomata, oral mucocutaneous hyperpigmentation,